AzTrials
AzTrials

Pseudoparalysis Due to Massive Rotator Cuff TearNCT03905499

Robot Assisted Physical Therapy for Pseudoparalysis in Massive Rotator Cuff Tear

A study testing Robotic assisted therapy with MJS (multi joint system) Tecnobody in people with Pseudoparalysis Due to Massive Rotator Cuff Tear, run by Schulthess Klinik at 1 site in Switzerland.

Available

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The primary objective of this study is to assess the efficacy of a robot assisted therapy in a clinical setting and its potential benefit for patients with rotator cuff tear associated with pseudoparalysis. Read more about this study

Who is it for?
Ages 18 years and older
What is being tested?
Robotic assisted therapy with MJS (multi joint system) Tecnobody
Type of treatment
Medical device
How many people
Not given
Where
1 siteSwitzerland
Study dates
Start not givento not given
Phase
Expanded access
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Active flexion <45°
  • Massive, irreparable, atraumatic RC tear at least two tendons
  • Almost full passive ROM glenohumeral (140-180°)
  • Fatty infiltration of the muscle Goutallier grade III or IV
  • Persistent loss of active ROM after injection
  • Ability to speak and understand German or English

Who cannot join

  • Neurological disease
  • Clinical diagnosis of rheumatoid arthritis, glenohumeral osteoarthritis, periarthritis and necrosis
  • RC repair in the previous two years
  • Acute fracture
  • Acute traumatic RC tear
  • Capsular shoulder stiffness

Trial locations and contacts

1 site in 1 country.

Switzerland1 site
  • Schulthess Klinik

    Zurich, Canton of Zurich, 8008

    Markus Scheibel, MD, +41443857468, markus.scheibel@kws.ch

    Asimina Lazaridou, PhD, +41443857580, Asimina.Lazaridou@kws.ch

    Available

Other trials in Switzerland

About this study

Official title: Can Robot Assited Physical Therapy Affect Pseudoparalysis in Patients Treated for Massive Rotator Cuff Tear? A Feasibility Study

The primary objective of this study is to assess the efficacy of a robot assisted therapy in a clinical setting and its potential benefit for patients with rotator cuff tear associated with pseudoparalysis. eighty patients with clinical signs of pseudoparalysis will be recruited through doctors and physical therapists based on eligibility criteria. After completing the baseline assessments, patients will be randomized into the robot-assisted physical therapy intervention or control comparison group. Enrolled patients will conduct a specific trainings program with the MJS Tecnobody (Multi Joint System 614P Tecnobody Srl, IT) three times a week over a period of six weeks. Feasibility assessment will be performed six and twelve weeks after baseline and secondary outcomes (Oxford shoulder score, subjective shoulder value, pain level during activity of daily living, active shoulder flexion and abduction and quality of life EQ-5D-5L) will be assessed at baseline, six and twelve weeks post intervention.

Read the detailed description

Rotator cuff tears are a common disorder in chronic shoulder pain. Common Complaints are pain, loss of range of motion and loss of strength. 20% of all tears are massive, in re-ruptures even 80%, with at least two tendons involved and this could lead to pseudoparalysis. The recommendation for the initial treatment is non-operative with physical therapy although people often receive a shoulder endoprosthesis. Robotic mediated therapy in patients with neurological disorders is already common, in rotator cuff tears it is less frequent and evidence is rare though. Therefore, the primary objective of this study is to evaluate the feasibility of a robotic mediated therapy in a clinical setting, in terms of satisfaction, compliance and tolerance, and its potential benefit for patients with rotator cuff tear associated with pseudoparalysis.

Eighty patients with clinical signs of pseudoparalysis will be recruited in the Schulthess clinic in Zurich through doctors and physical therapists of the shoulder and elbow surgery department based on eligibility criteria. Eligible patient will be enclosed after signing the informed consent. The patients will attend a specific trainings program with the MJS Tecnobody (Multi Joint System 614P Tecnobody Srl, IT) three times a week over a period of six weeks. The training is guided by a specialised physical therapist and the trainings program is developed by physical therapists and doctors of the Schulthess clinic based on current literature. Feasibility assessment will be performed six and twelve weeks after baseline and secondary outcomes (Oxford shoulder score, subjective shoulder value, pain level during activity of daily living, active shoulder flexion and abduction and quality of life EQ-5D-5L) will be assessed at baseline, six and twelve weeks post intervention. Primary analysis will be descriptive and secondary analysis will be analyzed with a univariate paired non-parametric analysis. All statistical tests will be two-sided and the level of significance will be set at p < 0.05. We will follow a repeated measures analysis to investigate changes in the outcomes variables across time. This approach allows for the examination of within-subject differences, making it particularly useful in studying interventions or treatments where individuals serve as their own control.

Being tested
Robotic assisted therapy with MJS (multi joint system) Tecnobody, Usual Care
Keywords
Massive rotator cuff tear, Pseudoparalysis, Robotic mediated therapy

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Robotic assisted therapy with MJS (multi joint system) TecnobodyDevice

    The intervention will include 18 30-minutes trainings evenly distributed over a time period of 6 weeks and will be administered by the same two physiotherapists at the Schulthess clinic based on the standardized protocol

  • Usual CareOther

    Patients randomized in the usual care will receive standard of care treatment without receiving any active intervention

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted5 Apr 2019

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Expanded access
IDs, dates and publications
ClinicalTrials.gov ID
NCT03905499
Sponsor's protocol ID
OE-0067 (RC-Pseudoparalysis)
Status last verified
May 2024
First submitted
3 Apr 2019
Last updated
7 Jun 2024
Results posted
No

Questions about this trial

What is this clinical trial studying?

A study testing Robotic assisted therapy with MJS (multi joint system) Tecnobody in people with Pseudoparalysis Due to Massive Rotator Cuff Tear, run by Schulthess Klinik at 1 site in Switzerland.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 7 Jun 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Switzerland. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Sabine Schibli (+41 44 385 7580, sabine.schibli@kws.ch), or a site near the patient. AzTrials does not enrol participants or take referrals.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 7 Jun 2024; AzTrials last refreshed its copy on 31 Oct 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in